Carnitine acts in skill transfer of long-chain fatty acids into the mitochondrial matrix to generate energy. The heart does not perform the biosynthesis of carnitine, although the cardiomyocytes require high levels of this compound. 1, 2 Under physiological conditions, the concentrations of carnitine in the myocardium are maintained by intestinal absorption biosynthesis, as well as by renal reabsorption and transport to cardiomyocytes. Changes in cardiac metabolism can lead to decreased cardiac carnitine concentration, which causes accumulation of free fatty acids and acylcarnitines that are not metabolized properly. 3 The open heart procedure may be more a factor of impact on the levels of carnitine. Thus, it is important to evaluate plasma levels to preserve the myocardial metabolic disorders resulting from deficiency of free carnitine. 4 Few studies address the concentrations of free carnitine in plasma of patients with chronic ischemia who undergo coronary artery bypass grafting (CABG). Thus, the aim of this study is to investigate whether the levels of free carnitine are affected by CABG.
Ten consecutive patients with left ventricular ejection fraction p50% (Teicholz) and chronic ischemic heart failure class II and III NYHA 5 who were admitted for elective CABG surgery at the National Institute of Cardiology (Rio de Janeiro, Brazil) between November 2012 and January 2013 were included in this study. The National Institute of Cardiology is a public hospital under the direction of the Ministry of Health, Brazil. Patients were excluded if they had preoperatively renal dysfunction, hepatic disorders, disabsorptive syndromes, any tumors or the ones who needed an intra-aortic balloon. They were also excluded if there were perioperative cerebral vascular accident, dysphagia, and sepsis or required dialysis, postoperatively.
All study procedures were in agreement with the standards of the research ethics committees of the Fluminense Federal University, the National Institute of Cardiology, and Helsinai Declaration. To assess free carnitine levels, the enzymatic spectrophotometric method was used. 6 Three blood samples were analyzed: preoperative; at 2 days postoperative; and at 12 days postoperative. Data about patient characteristics were analyzed by column statistics; data about free carnitine levels were analyzed by one-way analysis of variance repeated measures, followed by a Tukey post-test, and expressed as means±s.e.m. with significance level of 0.05.
Patients characteristics are shown in Table 1 . In the day-2 postoperative samples, plasma/carnitine levels had decreased by 37% (Po0.05, 30.63±4.67 nM) compared with preoperative levels (48.73±5.19 nM). In the day-12 postoperative samples, levels remained low (37%; Po0.05, 30.50 ± 3.45 nM; Figure 1 ). In summary, this study shows that after CABG a decrease in circulating carnitine levels is sustained up to 12 days. Previously, Nemoto et al., 4 studying 11 patients, reported that plasmatic carnitine levels decrease 2 h after open heart surgery. This study, with a more homogeneous patient population, reports a sustained lower carnitine levels for at least 12 days after the surgical procedure. The impact of these findings is still missing, but opens a hypothesis whether adding L-carnitine to this patient population will alter the results of the surgical procedure.
